Department of Cardiovascular Surgery, İstanbul Sultan 2. Abdülhamid Han Training and Research Hospital, İstanbul, Turkey.
Department of Cardiovascular Surgery, Kırklareli Training and Research Hospital, Kırklareli, Turkey.
Braz J Cardiovasc Surg. 2022 Dec 1;37(6):801-806. doi: 10.21470/1678-9741-2021-0439.
In this study, we aimed to present three different methods for symptomatic aberrant right subclavian artery (ARSA) surgery.
We identified 11 consecutive adult patients undergoing symptomatic and/or aneurysmal ARSA repair between January 2016 and December 2020. Symptoms were dysphagia (n=8) and dyspnea + dysphagia (n=3). Six patients had aneurysm formation of the ARSA (mean diameter of 4.2 cm [range 2.8 - 6.3]). All data were analyzed retrospectively.
Median age of the patients (7 females/4 males) was 55 years (range 49 - 62). The first four patients (36.4%) underwent hybrid repair using thoracic endovascular aortic repair (TEVAR) and bilateral carotid-subclavian artery bypass (CScBp). Three patients (27.2%) were treated by open ARSA resection/ligation with left mini posterolateral thoracotomy (LMPLT) and right CScBp. And the last four patients (36.4%) underwent ARSA resection/ligation with LMPLT and ascending aorta-right subclavian artery bypass with upper mini sternotomy (UMS). Two of the four patients who underwent TEVAR + bilateral CScBp had continuing dysphagia cause of persistent esophageal compression. Brachial plexus injury developed in one of three patients who underwent LMPLT + right CScBp. Pleural effusion treated with thoracentesis alone was observed in one of four patients who underwent UMS + LMPLT.
Among the symptomatic and/or aneurysmal ARSA treatment approaches, surgical and hybrid methods are used. There is still no consensus on how to manage these patients. In our study, we recommend the UMS + LMPLT method, since the risk of complications with anatomical bypass is less, and we have more successful surgical results.
本研究旨在介绍三种治疗症状性右位主动脉弓(ARSA)的不同方法。
我们回顾性分析了 2016 年 1 月至 2020 年 12 月期间连续 11 例接受症状性和/或 ARSA 动脉瘤修复的成年患者。症状包括吞咽困难(n=8)和呼吸困难+吞咽困难(n=3)。6 例患者出现 ARSA 瘤形成(平均直径 4.2cm[范围 2.8-6.3])。所有数据均进行回顾性分析。
患者的中位年龄(7 名女性/4 名男性)为 55 岁(范围 49-62 岁)。前 4 例患者(36.4%)采用经胸主动脉腔内修复术(TEVAR)和双侧颈总动脉-锁骨下动脉旁路术(CScBp)进行杂交修复。3 例患者(27.2%)采用左后外侧开胸术(LMPLT)和右 CScBp 进行开放 ARSA 切除/结扎。最后 4 例患者(36.4%)采用 LMPLT 和经升主动脉-右锁骨下动脉旁路术+小胸骨上开胸术(UMS)进行 ARSA 切除/结扎。4 例接受 TEVAR+CScBp 的患者中,有 2 例因食管持续受压而持续出现吞咽困难。3 例接受 LMPLT+右 CScBp 的患者中有 1 例发生臂丛神经损伤。4 例接受 UMS+LMPLT 的患者中,有 1 例出现胸腔积液,仅行胸腔穿刺治疗。
在治疗症状性和/或 ARSA 的方法中,可采用手术和杂交方法。目前对于如何处理这些患者仍未达成共识。在我们的研究中,我们推荐 UMS+LMPLT 方法,因为解剖旁路的并发症风险较小,且我们有更成功的手术结果。